Stock ASLN ASLAN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ASLAN Pharmaceuticals Limited

Equities

ASLN

US04522R2004

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
0.4153 USD -7.30% Intraday chart for ASLAN Pharmaceuticals Limited -18.89% -20.46%
26/04 Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5% MT
25/04 Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading MT

Evolution of the average Target Price on ASLAN Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

a3dbf8dd72d40bd.7l-s_4EedSgMK9DqxY6R0iaBuk7T3kMNe7TeQPORm_8.gjeYtel3FGI0Uf3Srfv5nXzR3w3kphJYGdiIc4Pj9cm9OceP7XgTGUJptw~39146b46fe7549a637e8e4985b30dc56

Analyst Recommendations on ASLAN Pharmaceuticals Limited

HC Wainwright Cuts ASLAN Pharmaceuticals Price Target to $9 From $17, Maintains Buy Rating MT
Piper Sandler Cuts ASLAN Pharmaceuticals' Price Target to $10 From $15, Maintains Overweight Rating MT
Roth MKM Initiates ASLAN Pharmaceuticals at Buy With $15 Price Target MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $3 From $4, Maintains Overweight Rating MT
HC Wainwright Adjusts Price Target on ASLAN Pharmaceuticals to $4.50 From $7, Keeps Buy Rating MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $4 From $3, Reiterates Overweight Rating MT
Piper Sandler Adjusts ASLAN Pharmaceuticals' Price Target to $3 from $8, Keeps Overweight Rating MT
ASLAN PHARMACEUTICALS : Jefferies & Co Initiates Coverage on ASLAN Pharmaceuticals With Buy Rating, $8 Price Target MT
ASLAN PHARMACEUTICALS : HC Wainwright Adjusts ASLAN Pharmaceuticals' Price Target to $8 from $5, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.4153 USD
Average target price
9.5 USD
Spread / Average Target
+2,187.50%
High Price Target
10 USD
Spread / Highest target
+2,307.90%
Low Price Target
9 USD
Spread / Lowest Target
+2,067.11%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ASLAN Pharmaceuticals Limited

HC Wainwright
Piper Sandler
Roth MKM
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ASLN Stock
  4. Consensus ASLAN Pharmaceuticals Limited